Hillstream BioPharma Regained Compliance With Nasdaq Listing Minimum Bid Price Rule

Hillstream BioPharma, Inc. (NASDAQ: HILS) today announced that it has regained compliance with the Nasdaq listing minimum bid price requirement for continued listing on the Nasdaq Capital Market exchange.

Hillstream BioPharma, Inc. (NASDAQ:HILS) today announced that it has regained compliance with the Nasdaq listing minimum bid price requirement for continued listing on the Nasdaq Capital Market exchange.

Total
0
Shares
Related Posts
Read More

Musk Sides With Harshest Fed Critic, Bitcoin Gets Gloomy Prediction, Amazon, Berkshire In Focus With Biden’s Tax Law And More: 5 Key Stories You May Have Missed From The Weekend

Following the Fed-induced sell-off in the week ended Sept. 23, discussions over the weekend centered around whether Federal Reserve Chairman Jerome Powell and his team would announce yet another aggressive rate hike. Here is a quick roundup of five stories you may have missed from the weekend:

AMZN

Read More

Why Real Estate Company Five Point Holdings Shares Are Surging Today

Five Point Holdings (FPH) witnesses a meteoric 11% stock surge post-reporting Q4 FY23 results. Led by substantial land sales, the company's $118.8 million revenues, notably from Valencia and Great Park Venture, showcase a formidable performance. CEO Dan Hedigan highlights a resilient strategy in navigating economic challenges and a housing shortage.

FPH